Tandem Diabetes Care Inc [TNDM] stock is trading at $30.15, up 8.18%. An important factor to consider is whether the stock is rising or falling in short-term value. The TNDM shares have gain 1.62% over the last week, with a monthly amount drifted -10.11%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Tandem Diabetes Care Inc [NASDAQ: TNDM] stock has seen the most recent analyst activity on November 06, 2024, when Bernstein initiated its Outperform rating and assigned the stock a price target of $42. Previously, Goldman started tracking the stock with Neutral rating on October 04, 2024, and set its price target to $46. On October 02, 2024, RBC Capital Mkts initiated with a Outperform rating and assigned a price target of $65 on the stock. Morgan Stanley started tracking the stock assigning a Equal-Weight rating and suggested a price target of $45 on August 22, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $57 as its price target on August 08, 2024. Redburn Atlantic started tracking with a Buy rating for this stock on May 30, 2024, and assigned it a price target of $60. In a note dated May 22, 2024, Citigroup upgraded an Buy rating on this stock and boosted its target price from $40 to $57.
Tandem Diabetes Care Inc [TNDM] stock has fluctuated between $17.33 and $53.69 over the past year. Currently, Wall Street analysts expect the stock to reach $79.05 within the next 12 months. Tandem Diabetes Care Inc [NASDAQ: TNDM] shares were valued at $30.15 at the most recent close of the market. An investor can expect a potential return of 162.19% based on the average TNDM price forecast.
Analyzing the TNDM fundamentals
Tandem Diabetes Care Inc [NASDAQ:TNDM] reported sales of 854.35M for the trailing twelve months, which represents a growth of 31.43%. Gross Profit Margin for this corporation currently stands at 0.44% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.13%, and Net Profit Margin reading is -0.13%. To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.49 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.26 points at the first support level, and at 26.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 31.19, and for the 2nd resistance point, it is at 32.22.
Ratios To Look Out For
For context, Tandem Diabetes Care Inc’s Current Ratio is 2.90. On the other hand, the Quick Ratio is 2.32, and the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 2.32, the price to book ratio is 8.33.
Transactions by insiders
Recent insider trading involved BLICKENSTAFF KIM D, Board of Directors Chair Emeri, that happened on Nov 20 ’24 when 10000.0 shares were purchased. EVP & CHIEF COMMERCIAL OFFICER, Novara Mark David completed a deal on Nov 15 ’24 to buy 532.0 shares. Meanwhile, Director Allen Dick sold 5000.0 shares on May 30 ’24.
